Skip Nav Destination
Progress in Tumor Research
Current Cancer ImmunologyAvailable to Purchase
Edited by
S.Karger AG
Volume
25
Status:
Available
ISBN electronic:
978-3-318-04178-1
ISBN print:
978-3-8055-3033-0
Subject Area:
Further Areas
,
Immunology and Allergy
,
Oncology
,
Pathology and Cell Biology
,
Surgery
Discontinued Book Series:
Progress in Tumor Research
Published online:
2015
Published in print:
1980
Current Cancer Immunology
Edited by: V. Richards
https://doi.org/10.1159/isbn.978-3-318-04178-1
ISBN (print): 978-3-8055-3033-0
ISBN (electronic): 978-3-318-04178-1
Publisher: S.Karger AG
Published: 1980
Download citation file:
Digital Version
Pay-Per-View Access
$171.00
Print Version
Current Cancer Immunology
$171.00
Table of Contents
-
1 - 60: Cancer Immunology — An OverviewByVictor RichardsVictor RichardsUniversity of California and Stanford Medical School, Chief of Surgery, Children’s Hospital, San Francisco, Calif.Search for other works by this author on:
-
61 - 88: Immunotherapy of Cancer: Current Status1ByJames E. Goodnight;James E. GoodnightDivision of Oncology, Department of Surgery, UCLA School of Medicine, Los Angeles, Calif., and the Department of Surgical Services, Veterans Administration Hospital, Sepulveda, Calif.Search for other works by this author on:Donald L. MortonDonald L. MortonDivision of Oncology, Department of Surgery, UCLA School of Medicine, Los Angeles, Calif., and the Department of Surgical Services, Veterans Administration Hospital, Sepulveda, Calif.Search for other works by this author on:
-
89 - 139: Immunologic Approaches to Diagnosis of MalignancyByJ. Shuster;J. ShusterDivision of Clinical Immunology and Allergy, Montreal General Hospital and the McGill Cancer Centre, McGill University, Montreal, Que.Search for other works by this author on:D. M. P. Thomson;D. M. P. ThomsonDivision of Clinical Immunology and Allergy, Montreal General Hospital and the McGill Cancer Centre, McGill University, Montreal, Que.Search for other works by this author on:A. Fuks;A. FuksDivision of Clinical Immunology and Allergy, Montreal General Hospital and the McGill Cancer Centre, McGill University, Montreal, Que.Search for other works by this author on:P. GoldP. GoldDivision of Clinical Immunology and Allergy, Montreal General Hospital and the McGill Cancer Centre, McGill University, Montreal, Que.Search for other works by this author on:
-
140 - 162: Serotherapy of Malignant Disease1ByP. W. Wright;P. W. WrightDivisions of Tumor Immunology and Pediatric Oncology, Fred Hutchinson Cancer Research Center and Departments of Medicine, Microbiology, and Pediatrics, University of Washington, Seattle, Wash.Search for other works by this author on:I. D. BernsteinI. D. BernsteinDivisions of Tumor Immunology and Pediatric Oncology, Fred Hutchinson Cancer Research Center and Departments of Medicine, Microbiology, and Pediatrics, University of Washington, Seattle, Wash.Search for other works by this author on:
-
163 - 177: Mediation of Immune Responses to Tumor Antigens by Immune RNA1ByYosef H. PilchYosef H. PilchDepartment of Surgery, University of California Medical Center, San Diego, Calif.Search for other works by this author on:
-
178 - 192: BCG, Levamisole and Transfer Factor in the Treatment of CancerByLynn E. SpitlerLynn E. SpitlerPaul M. Aggeler Memorial Laboratory, Children’s Hospital of San Francisco, and Department of Medicine, University of California Medical Center, San Francisco, Calif.Search for other works by this author on:
-
193 - 218: Tumor Immunology, T Cell Maturation, and T Cell NeoplasiaByI. L. WeissmanI. L. WeissmanStanford University Medical Center, Stanford, Calif.Search for other works by this author on:
-
219 - 228: The Effects of Combined Radiation Therapy and Chemotherapy on the Immune ResponseByA. M. MarkoeA. M. MarkoeDepartment of Radiation Therapy and Nuclear Medicine, The Hahnemann Medical College and Hospital of Philadelphia, Philadelphia, Pa.Search for other works by this author on:
-
229 - 241: Immune Adjuvant Therapy in Lung Cancer1ByE. Carmack HolmesE. Carmack HolmesDivision of Oncology, Department of Surgery, UCLA School of Medicine, Los Angeles, Calif.Search for other works by this author on:
-
242 - 274: Active Immunotherapy of Cancer for Minimal Residual Disease: New Trends and New MaterialsByG. Mathé;G. MathéHôpital Paul-Brousse, Institut de Cancérologie et d’Immunogénétique, VillejuifSearch for other works by this author on:I. Florentin;I. FlorentinHôpital Paul-Brousse, Institut de Cancérologie et d’Immunogénétique, VillejuifSearch for other works by this author on:L. Olsson;L. OlssonHôpital Paul-Brousse, Institut de Cancérologie et d’Immunogénétique, VillejuifSearch for other works by this author on:N. Kiger;N. KigerHôpital Paul-Brousse, Institut de Cancérologie et d’Immunogénétique, VillejuifSearch for other works by this author on:M. Bruley-Rosset;M. Bruley-RossetHôpital Paul-Brousse, Institut de Cancérologie et d’Immunogénétique, VillejuifSearch for other works by this author on:S. Orbach-Arbouys;S. Orbach-ArbouysHôpital Paul-Brousse, Institut de Cancérologie et d’Immunogénétique, VillejuifSearch for other works by this author on:J. I. SchulzJ. I. SchulzHôpital Paul-Brousse, Institut de Cancérologie et d’Immunogénétique, VillejuifSearch for other works by this author on:
-
275 - 292: Systemic Adjuvant Therapy with BCG Versus BCG + 5FU in Colorectal Cancer Dukes’ Class C Updated Critical AnalysisByGiora M. MavligitGiora M. MavligitThe University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Tex.Search for other works by this author on:
